Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Genpact LTDG · Entity 3760 | Director | February 18, 2025 | February 20, 2025 |
| JABIL INCJBL · Entity 3138 | Director | July 17, 2026 | August 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Genpact LTD
Report date February 18, 2025 · Filed February 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 604,631 |
Reported balance
After 2025-02-18 transaction · row 1
1 source rowRow 1 · 2025-02-18 · Sale · Disposed 108,880 · Balance 604,631 F1: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $54.62 to $55.26. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| Common SharesSEC Table I · non-derivative | IndirectBy Trust | 5,300 |
Reported balance
Holding disclosure · report date 2025-02-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,300 F2: These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $54.62 to $55.26. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2: These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein.
JABIL INC
Report date July 17, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,464 |
Reported balance
After 2026-07-17 transaction · row 1
1 source rowRow 1 · 2026-07-17 · Purchase · Acquired 500 · Balance 3,464 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 17, 2026 Filed Aug 5, 2026 20:04 UTC | JABIL INC JBL · Entity 3138 | PurchaseCommon Stock | 500 | $299.63 | $149,814.95 |
DisclosureSEC source: 0001225208-26-006945 · doc4.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,464 Read SEC document |
| April 23, 2026 Filed Apr 29, 2026 21:10 UTC | JABIL INC JBL · Entity 3138 | GrantCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004703 · doc4.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,964 F1 · kind: Restricted Stock Units ("RSUs") granted pursuant to Issuer's 2021 Equity Incentive Plan ("Plan"), each representing the right to receive one share of Issuer's Common Stock upon vesting. The RSUs vest on January 22, 2027, subject to the terms of the Plan. Read SEC document |
| January 23, 2026 Filed Jan 26, 2026 23:08 UTC | JABIL INC JBL · Entity 3138 | Tax withholdingCommon Stock | 147 | $244.70 | $35,970.90 |
DisclosureSEC source: 0001225208-26-000858 · doc4.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,364 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:11 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 108,880 | $54.87 | $5,974,245.60 |
DisclosureSEC source: 0001398659-25-000033 · wk-form4_1740085859.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 604,631 F1 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $54.62 to $55.26. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| January 25, 2025 Filed Jan 27, 2025 21:43 UTC | JABIL INC JBL · Entity 3138 | Tax withholdingCommon Stock | 89 | $173.33 | $15,426.37 |
DisclosureSEC source: 0001225208-25-000903 · doc4.xml · nonDerivative · entry 2 Tyagarajan N. V. · CIK 0001408239 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,511 Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:43 UTC | JABIL INC JBL · Entity 3138 | GrantCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000903 · doc4.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,600 F1 · kind: Restricted Stock Units ("RSUs") granted pursuant to Issuer's 2021 Equity Incentive Plan ("Plan"), each representing the right to receive one share of Issuer's Common Stock upon vesting. The RSUs vest on January 23, 2026, subject to the terms of the Plan. Read SEC document |
| January 17, 2025 Filed Jan 17, 2025 23:25 UTC | Genpact LTD G · Entity 3760 | Tax withholdingCommon Shares | 47,972 | $43.34 | $2,079,106.48 |
DisclosureSEC source: 0001398659-25-000023 · wk-form4_1737156299.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 713,511 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted share units and performance share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 21:39 UTC | Genpact LTD G · Entity 3760 | Tax withholdingCommon Shares | 55,000 | $42.38 | $2,330,900.00 |
DisclosureSEC source: 0001398659-25-000017 · wk-form4_1736890752.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 706,483 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted share units and performance share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3. Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 21:13 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 2,000 | $46.70 | $93,400.00 |
DisclosureSEC source: 0001398659-24-000106 · wk-form4_1731618800.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 5,300 F1 · ownership.nature: These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein. Read SEC document |
| June 05, 2024 Filed Jun 10, 2024 20:13 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 1,000 | $33.17 | $33,170.00 |
DisclosureSEC source: 0001398659-24-000081 · wk-form4_1718050420.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 7,300 F1 · ownership.nature: These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein. Read SEC document |
| May 02, 2024 Filed May 6, 2024 20:24 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 6,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001398659-24-000073 · wk-form4_1715027074.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 761,483 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2024 and will be settled in common shares on December 31, 2025. Read SEC document |
| January 25, 2024 Filed Jan 29, 2024 21:55 UTC | JABIL INC JBL · Entity 3138 | GrantCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-001258 · doc4.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,300 F1 · kind: Restricted Stock Units ("RSUs") granted pursuant to Issuer's 2021 Equity Incentive Plan ("Plan"), each representing the right to recieve one share of Issuer's Common Stock upon vesting. The RSUs vest on January 25, 2025, subject to the terms of the Plan. Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 21:52 UTC | Genpact LTD G · Entity 3760 | Tax withholdingCommon Shares | 50,733 | $34.27 | $1,738,619.91 |
DisclosureSEC source: 0001398659-24-000021 · wk-form4_1705614740.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 754,776 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted share units and performance share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan and exempt under Rule 16b-3. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 21:47 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 1,700 | $35.89 | $61,014.36 |
DisclosureSEC source: 0001398659-23-000030 · wk-form4_1692395263.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 8,300 F1 · ownership.nature: These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein. Read SEC document |
| May 19, 2023 Filed May 22, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001140361-23-025988 · form4.xml · derivative · entry 7 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 50,000 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. Read SEC document |
| May 19, 2023 Filed May 22, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 50,000 | $38.49 | $1,924,305.00 |
DisclosureSEC source: 0001140361-23-025988 · form4.xml · nonDerivative · entry 4 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 805,509 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $38.07 to $38.98. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 19, 2023 Filed May 22, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 50,000 | $19.35 | $967,500.00 |
DisclosureSEC source: 0001140361-23-025988 · form4.xml · nonDerivative · entry 3 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 855,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. Read SEC document |
| May 18, 2023 Filed May 22, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001140361-23-025988 · form4.xml · derivative · entry 6 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. Read SEC document |
| May 18, 2023 Filed May 22, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 50,000 | $37.95 | $1,897,300.00 |
DisclosureSEC source: 0001140361-23-025988 · form4.xml · nonDerivative · entry 2 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 805,509 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $37.69 to $38.222. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 18, 2023 Filed May 22, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 50,000 | $19.35 | $967,500.00 |
DisclosureSEC source: 0001140361-23-025988 · form4.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 855,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. Read SEC document |
| May 17, 2023 Filed May 18, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001140361-23-025482 · form4.xml · derivative · entry 8 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 50,000 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. Read SEC document |
| May 17, 2023 Filed May 18, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 700 | $37.74 | $26,418.00 |
DisclosureSEC source: 0001140361-23-025482 · form4.xml · nonDerivative · entry 5 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 805,509 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. Read SEC document |
| May 17, 2023 Filed May 18, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 49,300 | $37.27 | $1,837,539.18 |
DisclosureSEC source: 0001140361-23-025482 · form4.xml · nonDerivative · entry 4 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 806,209 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $36.74 to $37.71. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 17, 2023 Filed May 18, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 50,000 | $19.35 | $967,500.00 |
DisclosureSEC source: 0001140361-23-025482 · form4.xml · nonDerivative · entry 3 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 855,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001140361-23-025482 · form4.xml · derivative · entry 7 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Shares · 50,000 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 50,000 | $36.73 | $1,836,630.00 |
DisclosureSEC source: 0001140361-23-025482 · form4.xml · nonDerivative · entry 2 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 805,509 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $36.54 to $37.10. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:12 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 50,000 | $19.35 | $967,500.00 |
DisclosureSEC source: 0001140361-23-025482 · form4.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 855,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001140361-23-023206 · form4.xml · derivative · entry 8 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Shares · 50,000 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 2,170 | $41.96 | $91,044.09 |
DisclosureSEC source: 0001140361-23-023206 · form4.xml · nonDerivative · entry 5 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 805,509 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F4 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $41.87 to $42.02. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 47,830 | $41.20 | $1,970,419.03 |
DisclosureSEC source: 0001140361-23-023206 · form4.xml · nonDerivative · entry 4 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 807,679 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.83 to $41.77. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 50,000 | $19.35 | $967,500.00 |
DisclosureSEC source: 0001140361-23-023206 · form4.xml · nonDerivative · entry 3 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 855,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001140361-23-023206 · form4.xml · derivative · entry 7 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Shares · 50,000 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 50,000 | $43.39 | $2,169,285.00 |
DisclosureSEC source: 0001140361-23-023206 · form4.xml · nonDerivative · entry 2 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 805,509 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.052 to $43.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 03, 2023 Filed May 5, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 50,000 | $19.35 | $967,500.00 |
DisclosureSEC source: 0001140361-23-023206 · form4.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 855,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:11 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001140361-23-022706 · form4.xml · derivative · entry 8 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Shares · 50,000 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:11 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 3,684 | $44.55 | $164,133.62 |
DisclosureSEC source: 0001140361-23-022706 · form4.xml · nonDerivative · entry 5 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 805,509 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F4 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.46 to $44.58. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:11 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 46,316 | $43.79 | $2,028,335.11 |
DisclosureSEC source: 0001140361-23-022706 · form4.xml · nonDerivative · entry 4 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 809,193 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.45 to $44.44. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:11 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 50,000 | $19.35 | $967,500.00 |
DisclosureSEC source: 0001140361-23-022706 · form4.xml · nonDerivative · entry 3 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 855,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:11 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001140361-23-022706 · form4.xml · derivative · entry 7 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Shares · 50,000 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:11 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 50,000 | $44.49 | $2,224,315.00 |
DisclosureSEC source: 0001140361-23-022706 · form4.xml · nonDerivative · entry 2 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 805,509 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.29 to $44.59. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:11 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 50,000 | $19.35 | $967,500.00 |
DisclosureSEC source: 0001140361-23-022706 · form4.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 855,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. Read SEC document |
| April 06, 2023 Filed Apr 7, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001140361-23-017332 · form4.xml · derivative · entry 7 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Shares · 50,000 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. Read SEC document |
| April 06, 2023 Filed Apr 7, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 50,000 | $44.87 | $2,243,530.00 |
DisclosureSEC source: 0001140361-23-017332 · form4.xml · nonDerivative · entry 4 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 805,509 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.732 to $45.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 06, 2023 Filed Apr 7, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 50,000 | $19.35 | $967,500.00 |
DisclosureSEC source: 0001140361-23-017332 · form4.xml · nonDerivative · entry 3 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 855,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001140361-23-017332 · form4.xml · derivative · entry 6 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Shares · 50,000 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 50,000 | $45.18 | $2,258,850.00 |
DisclosureSEC source: 0001140361-23-017332 · form4.xml · nonDerivative · entry 2 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 805,509 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F2 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.90 to $45.69. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 50,000 | $19.35 | $967,500.00 |
DisclosureSEC source: 0001140361-23-017332 · form4.xml · nonDerivative · entry 1 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 855,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. Read SEC document |
| April 04, 2023 Filed Apr 5, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $19.35 | $0.00 |
DisclosureSEC source: 0001140361-23-016709 · form4.xml · derivative · entry 7 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Shares · 50,000 shares Expires 2023-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. Read SEC document |
| April 04, 2023 Filed Apr 5, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 50,000 | $45.46 | $2,273,095.00 |
DisclosureSEC source: 0001140361-23-016709 · form4.xml · nonDerivative · entry 4 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 805,509 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. F3 · price: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $45.24 to $46.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 04, 2023 Filed Apr 5, 2023 20:10 UTC | Genpact LTD G · Entity 3760 | Exercise / conversionCommon Shares | 50,000 | $19.35 | $967,500.00 |
DisclosureSEC source: 0001140361-23-016709 · form4.xml · nonDerivative · entry 3 Tyagarajan N. V. · CIK 0001408239 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 855,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.